Sun Pharmaceutical has agreed to acquire 100 percent outstanding shares of Innovcare Lifesciences for INR 271.2 crore.

Innovcare Lifescience is engaged in the business of marketing, distribution and sale of pharmaceutical drugs, nutraceutical and cosmeceutical products.

The company's revenue from operations for FY 2025-26 was INR 94.06 crores.

Sun Pharma stated that the deal is expected to close on or before July 31, 2026. The company said that the acquisition forms strategic investment to strengthen product portfolio of the company.